>細胞CELL>biobw自建細胞系>鴨胚胎干細胞EB66*
細胞名稱:鴨胚胎干細胞EB66
產品規(guī)格:T25培養(yǎng)瓶x1;1.5ml凍存管x2
細胞數量:1x10^6;1x10^6
保存溫度:37℃;-198℃
運輸方式:常溫保溫運輸;干冰運輸
安全等級:1
用途限制:僅供科研G類
培養(yǎng)體系:干細胞專用培養(yǎng)基/無血清專用培養(yǎng)基
培養(yǎng)溫度:37℃
二氧化碳濃度:5%
簡介:鴨胚胎干細胞EB66取自雄性綠頭鴨胚胎.
注釋:倍增時間41h
基因突變:/
HLA信息:/
STR信息:/
參考文獻:PubMed=20562528
Olivier S.,Jacoby M.,Brillon C.,Bouletreau S.,Mollet T.,Nerriere O.,Angel A.,Danet S.,Souttou B.,Guehenneux F.,Gauthier L.,Berthome M.,Vie H.,Beltraminelli N.,Mehtali M.
EB66 cell line,a duck embryonic stem cell-derived substrate for the industrial production of therapeutic monoclonal antibodies with enhanced ADCC activity.
MAbs 2:405-415(2010)
PubMed=21502045
Brown S.W.,Mehtali M.
The avian EB66(R)cell line,application to vaccines,and therapeutic protein production.
PDA J.Pharm.Sci.Technol.64:419-425(2010)
PubMed=25903999;DOI=10.1002/biot.201400388
Genzel Y.
Designing cell lines for viral vaccine production:where do we stand?
Biotechnol.J.10:728-740(2015)
PubMed=26409141;DOI=10.1016/j.vaccine.2015.09.022
Naruse T.,Fukuda T.,Tanabe T.,Ichikawa M.,Oda Y.,Tochihara S.,Kimachi K.,Kino Y.,Ueda K.
A clinical phase I study of an EB66 cell-derived H5N1 pandemic vaccine adjuvanted with AS03.
Vaccine 33:6078-6084(2015)
Patent=US9260694
Guehenneux F.,Moreau K.,Esnault M.,Mehtali M.
Generation of duck cell lines.
Patent number US9260694,16-Feb-2016
細胞操作說明下載:細胞操作說明